Effect of Dihydrocapsiate on Energy Expenditure in Women
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dihydrocapsiate
Sponsored by

About this trial
This is an interventional prevention trial for Obesity focused on measuring Obesity, Body Weight, Body Composition, Metabolism, Resting Energy Expenditure
Eligibility Criteria
Inclusion Criteria:
- BMI: 18.5-34.5 kg/m2
- Good general health
- Low to mild physical activity
- Willing to maintain habitual diet and physical activity patterns throughout the study period
- Premenopausal and cycling regularly or using oral contraceptives
- Willing to attend study visits only during the follicular phase or bleed phase of their menstrual cycle
- Understands study procedures and signs forms providing informed consent to participate in the study
- Have spoken and written English literacy
Exclusion Criteria:
- Diabetes mellitus or any conditions that might affect energy metabolism
- Weight change ±2 kg over previous three months
- Known sensitivity or allergy to ingredients of the study products
- Non-breakfast eater
- Recent use of antibiotics
- History of smoking during the six months prior to study
- Recent signs or symptoms of infection, including cold or flu-like symptoms
- Concurrent or recent intervention study participation
- Instability in breathing patterns or energy expenditure measures
- History of drug or alcohol abuse
- Lipid-lowering, anti-hypertensive or anti-inflammatory steroid medication use
- Weight loss medication
- Pregnant or lactating
- Unwilling to be randomized to any experimental group and unable to meet all requirements of the study
Sites / Locations
- University of Georgia, Department of Kinesiology
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
Placebo 0 mg/d
Dihydrocapsiate 9 mg/d
Arm Description
0 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers
9 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers
Outcomes
Primary Outcome Measures
Resting Energy Expenditure
Secondary Outcome Measures
Thermic effect of feeding
Body Composition
Full Information
NCT ID
NCT01773356
First Posted
January 15, 2013
Last Updated
September 24, 2015
Sponsor
Ellen Evans
Collaborators
Kellogg Company
1. Study Identification
Unique Protocol Identification Number
NCT01773356
Brief Title
Effect of Dihydrocapsiate on Energy Expenditure in Women
Official Title
Randomized, Controlled, Parallel Trial to Evaluate the Effects of Dihydrocapsiate on Energy Expenditure in Women
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ellen Evans
Collaborators
Kellogg Company
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study is to test the effect of dihydrocapsiate on energy expenditure in women.
Detailed Description
Capsaicin, a substance found in chili pepper, is known to stimulate thermogenesis. Dihydrocapsiate, a capsinoid, found in the non-pungent CH-19 sweet pepper has similar thermogenic effects without the gastrointestinal side effects. The objective of this project is to test the effect of 12 weeks of daily consumption of 9 mg dihydrocapsiate on resting energy expenditure relative to baseline when compared to a control group consuming products without DCT.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Obesity, Body Weight, Body Composition, Metabolism, Resting Energy Expenditure
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
126 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo 0 mg/d
Arm Type
Placebo Comparator
Arm Description
0 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers
Arm Title
Dihydrocapsiate 9 mg/d
Arm Type
Active Comparator
Arm Description
9 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers
Intervention Type
Dietary Supplement
Intervention Name(s)
Dihydrocapsiate
Other Intervention Name(s)
Natural substances present in sweet chili peppers
Intervention Description
Kellogg's ready to eat cereal, cereal bars, and crackers will contain dihyrocapsiate or placebo. Daily consumption of dihydrocapsiate is 9mg/d or 0mg/d.
Primary Outcome Measure Information:
Title
Resting Energy Expenditure
Time Frame
Change from Baseline at 12 weeks
Secondary Outcome Measure Information:
Title
Thermic effect of feeding
Time Frame
Change from baseline at 12 weeks
Title
Body Composition
Time Frame
Change from baseline at 12 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
BMI: 18.5-34.5 kg/m2
Good general health
Low to mild physical activity
Willing to maintain habitual diet and physical activity patterns throughout the study period
Premenopausal and cycling regularly or using oral contraceptives
Willing to attend study visits only during the follicular phase or bleed phase of their menstrual cycle
Understands study procedures and signs forms providing informed consent to participate in the study
Have spoken and written English literacy
Exclusion Criteria:
Diabetes mellitus or any conditions that might affect energy metabolism
Weight change ±2 kg over previous three months
Known sensitivity or allergy to ingredients of the study products
Non-breakfast eater
Recent use of antibiotics
History of smoking during the six months prior to study
Recent signs or symptoms of infection, including cold or flu-like symptoms
Concurrent or recent intervention study participation
Instability in breathing patterns or energy expenditure measures
History of drug or alcohol abuse
Lipid-lowering, anti-hypertensive or anti-inflammatory steroid medication use
Weight loss medication
Pregnant or lactating
Unwilling to be randomized to any experimental group and unable to meet all requirements of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ellen M Evans, Ph.D.
Organizational Affiliation
University of Georgia
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Georgia, Department of Kinesiology
City
Athens
State/Province
Georgia
ZIP/Postal Code
30602-6554
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Effect of Dihydrocapsiate on Energy Expenditure in Women
We'll reach out to this number within 24 hrs